Compare BIO & KNSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | KNSL |
|---|---|---|
| Founded | 1952 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Property-Casualty Insurers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.8B |
| IPO Year | N/A | 2016 |
| Metric | BIO | KNSL |
|---|---|---|
| Price | $299.97 | $380.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $358.50 | ★ $483.78 |
| AVG Volume (30 Days) | 163.5K | ★ 258.8K |
| Earning Date | 10-29-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 0.18% |
| EPS Growth | N/A | ★ 16.09 |
| EPS | N/A | ★ 20.35 |
| Revenue | ★ $2,557,500,000.00 | $1,802,839,000.00 |
| Revenue This Year | $1.77 | $19.56 |
| Revenue Next Year | $2.30 | $7.74 |
| P/E Ratio | ★ N/A | $18.93 |
| Revenue Growth | N/A | ★ 18.10 |
| 52 Week Low | $211.43 | $349.00 |
| 52 Week High | $373.69 | $512.76 |
| Indicator | BIO | KNSL |
|---|---|---|
| Relative Strength Index (RSI) | 38.48 | 46.87 |
| Support Level | $298.02 | $349.00 |
| Resistance Level | $319.50 | $401.15 |
| Average True Range (ATR) | 8.25 | 10.33 |
| MACD | -2.25 | 3.49 |
| Stochastic Oscillator | 3.23 | 60.81 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.